v3.26.1
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Common stock
Additional paid-in capital
Accumulated Other Comprehensive (Loss)
Accumulated deficit
Total
Beginning balance at Dec. 31, 2024 $ 3 $ 496,195 $ (211) $ (238,333) $ 257,654
Beginning balance (in shares) at Dec. 31, 2024 33,706,765        
Changes in stockholder's equity          
Issuance of common stock, net of issuance costs $ 1 6,516     6,517
Issuance of common stock, net of issuance costs (in shares) 264,458        
Exercise of stock options   293     293
Exercise of stock options (in shares) 69,773        
Stock-based compensation expense   2,271     2,271
Unrealized loss on marketable securities     194   194
Net Income (Loss)       (64,387) (64,387)
Ending balance at Mar. 31, 2025 $ 4 505,275 (17) (302,720) 202,542
Ending balance (in shares) at Mar. 31, 2025 34,040,996        
Beginning balance at Dec. 31, 2025 $ 4 711,847 14 (404,641) 307,224
Beginning balance (in shares) at Dec. 31, 2025 42,452,251        
Changes in stockholder's equity          
Issuance of common stock, net of issuance costs $ 1 54,724     54,725
Issuance of common stock, net of issuance costs (in shares) 2,425,495        
Exercise of stock options   150     $ 150
Exercise of stock options (in shares) 31,195       31,195
Exercise of pre-funded warrants (in shares) 400,000       400,000
Stock-based compensation expense   5,485     $ 5,485
Unrealized loss on marketable securities     (284)   (284)
Net Income (Loss)       (43,320) (43,320)
Ending balance at Mar. 31, 2026 $ 5 $ 772,206 $ (270) $ (447,961) $ 323,980
Ending balance (in shares) at Mar. 31, 2026 45,308,941